These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25015354)

  • 1. Safety assessment of docosahexaenoic acid in X-linked retinitis pigmentosa: the 4-year DHAX trial.
    Hughbanks-Wheaton DK; Birch DG; Fish GE; Spencer R; Pearson NS; Takacs A; Hoffman DR
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4958-66. PubMed ID: 25015354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX trial): a randomized clinical trial.
    Hoffman DR; Hughbanks-Wheaton DK; Pearson NS; Fish GE; Spencer R; Takacs A; Klein M; Locke KG; Birch DG
    JAMA Ophthalmol; 2014 Jul; 132(7):866-73. PubMed ID: 24805262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa.
    Wheaton DH; Hoffman DR; Locke KG; Watkins RB; Birch DG
    Arch Ophthalmol; 2003 Sep; 121(9):1269-78. PubMed ID: 12963609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docosahexaenoic Acid Slows Visual Field Progression in X-Linked Retinitis Pigmentosa: Ancillary Outcomes of the DHAX Trial.
    Hoffman DR; Hughbanks-Wheaton DK; Spencer R; Fish GE; Pearson NS; Wang YZ; Klein M; Takacs A; Locke KG; Birch DG
    Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6646-53. PubMed ID: 26469750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.
    Hoffman DR; Locke KG; Wheaton DH; Fish GE; Spencer R; Birch DG
    Am J Ophthalmol; 2004 Apr; 137(4):704-18. PubMed ID: 15059710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses.
    Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ
    Arch Ophthalmol; 2004 Sep; 122(9):1306-14. PubMed ID: 15364709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized placebo-controlled clinical trial of docosahexaenoic acid (DHA) supplementation for X-linked retinitis pigmentosa.
    Birch DG
    Retina; 2005 Dec; 25(8 Suppl):S52-S54. PubMed ID: 16374336
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.
    Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ
    Arch Ophthalmol; 2004 Sep; 122(9):1297-305. PubMed ID: 15364708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docosahexaenoic acid in red blood cells of patients with X-linked retinitis pigmentosa.
    Hoffman DR; Birch DG
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1009-18. PubMed ID: 7730010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa.
    Birch DG; Locke KG; Wen Y; Locke KI; Hoffman DR; Hood DC
    JAMA Ophthalmol; 2013 Sep; 131(9):1143-50. PubMed ID: 23828615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired synthesis of DHA in patients with X-linked retinitis pigmentosa.
    Hoffman DR; DeMar JC; Heird WC; Birch DG; Anderson RE
    J Lipid Res; 2001 Sep; 42(9):1395-401. PubMed ID: 11518758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin A and fish oils for retinitis pigmentosa.
    Rayapudi S; Schwartz SG; Wang X; Chavis P
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD008428. PubMed ID: 24357340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated prostaglandin E metabolites and abnormal plasma fatty acids at baseline in pediatric cystic fibrosis patients: a pilot study.
    O'Connor MG; Thomsen K; Brown RF; Laposata M; Seegmiller A
    Prostaglandins Leukot Essent Fatty Acids; 2016 Oct; 113():46-49. PubMed ID: 27720040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Docosahexaenoic Acid Supplementation vs Placebo on Developmental Outcomes of Toddlers Born Preterm: A Randomized Clinical Trial.
    Keim SA; Boone KM; Klebanoff MA; Turner AN; Rausch J; Nelin MA; Rogers LK; Yeates KO; Nelin L; Sheppard KW
    JAMA Pediatr; 2018 Dec; 172(12):1126-1134. PubMed ID: 30357263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study.
    Lloyd-Still JD; Powers CA; Hoffman DR; Boyd-Trull K; Lester LA; Benisek DC; Arterburn LM
    Nutrition; 2006 Jan; 22(1):36-46. PubMed ID: 16226012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients.
    Véricel E; Colas R; Calzada C; Lê QH; Feugier N; Cugnet C; Vidal H; Laville M; Moulin P; Lagarde M
    Thromb Haemost; 2015 Aug; 114(2):289-96. PubMed ID: 25832443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docosahexaenoic acid transfer into human milk after dietary supplementation: a randomized clinical trial.
    Fidler N; Sauerwald T; Pohl A; Demmelmair H; Koletzko B
    J Lipid Res; 2000 Sep; 41(9):1376-83. PubMed ID: 10974044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Prenatal Docosahexaenoic Acid Supplementation on Blood Pressure in Children With Overweight Condition or Obesity: A Secondary Analysis of a Randomized Clinical Trial.
    Kerling EH; Hilton JM; Thodosoff JM; Wick J; Colombo J; Carlson SE
    JAMA Netw Open; 2019 Feb; 2(2):e190088. PubMed ID: 30794304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of progressive loss of the ellipsoid zone (EZ) band in autosomal dominant and x-linked retinitis pigmentosa.
    Cai CX; Locke KG; Ramachandran R; Birch DG; Hood DC
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7417-22. PubMed ID: 25342618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the effect of dietary docosahexaenoic acid (DHA) supplementation on macular function in subjects with autosomal recessive Stargardt macular dystrophy.
    MacDonald IM; Sieving PA
    Ophthalmic Genet; 2018 Aug; 39(4):477-486. PubMed ID: 29912604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.